LSM3, NDUFB3, and PTGS2 may be potential biomarkers for BRCA1-mutation positive breast cancer

.blurhash-client-img { display: none !important; }

Open Access

|Nov 2020

Authors

Breast and Thyroid Disease Medical Center, Hospital of Zunyi Medical University, China

Breast and Thyroid Disease Medical Center, Hospital of Zunyi Medical University, China

Breast and Thyroid Disease Medical Center, Hospital of Zunyi Medical University, China

Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, China

Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, China

Department of Oncology Laboratory, Affiliated Hospital of Zunyi Medical University, China

Breast and Thyroid Disease Medical Center, Hospital of Zunyi Medical University, China

DOI: https://doi.org/10.2478/rrlm-2020-0037 | Journal eISSN: 2284-5623 | Journal ISSN: 1841-6624

Language: English

Page range: 381 - 391

Submitted on: Jul 23, 2020

Accepted on: Oct 28, 2020

Published on: Nov 18, 2020

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Related subjects:

© 2020 Kang Hu, Fengjiao Gan, Xue Wang, Lin Xu, Qiaoyuan Wu, Ni Jiang, Suhong Sun, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.